InnoCan Pharma Stock News
$0.16
0.00%
Nasdaq,
Dec 27, 03:30 pm CET
InnoCan Pharma Stock News
AD HOC NEWS
●
19 days ago
InnoCan Pharma Corporation / CA45783P1027
AD HOC NEWS
●
about one month ago
InnoCan Pharma Corporation / CA45783P1027
AD HOC NEWS
●
about one month ago
InnoCan Pharma Corporation / CA45783P1027
AD HOC NEWS
●
about 2 months ago
InnoCan Pharma Corporation / CA45783P1027
Neutral
MCAP MediaWire
●
2 months ago
Herzliya, Israel and Calgary, Alberta, October 21, 2024 – PRISM MediaWire – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in chronic pain management via Liposomal CBD drug products, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental
Neutral
GlobeNewsWire
●
2 months ago
HERZLIYA, Israel and CALGARY, Alberta, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in chronic pain management via Liposomal CBD drug products, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Co...
AD HOC NEWS
●
3 months ago
InnoCan Pharma Corporation / CA45783P1027
AD HOC NEWS
●
3 months ago
InnoCan Pharma Corporation / CA45783P1027
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
